NYSE - Delayed Quote USD
Alcon Inc. (ALC)
87.79
+0.86
+(0.99%)
At close: June 6 at 4:00:02 PM EDT
87.79
0.00
(0.00%)
After hours: June 6 at 6:00:06 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 26 | 25 |
Avg. Estimate | 0.76 | 0.84 | 3.23 | 3.83 |
Low Estimate | 0.76 | 0.84 | 3.2 | 3.68 |
High Estimate | 0.77 | 0.84 | 3.28 | 3.99 |
Year Ago EPS | 0.74 | 0.81 | 3.05 | 3.23 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 20 | 21 |
Avg. Estimate | 2.65B | 2.64B | 10.47B | 11.24B |
Low Estimate | 2.62B | 2.59B | 10.39B | 11.02B |
High Estimate | 2.67B | 2.67B | 10.61B | 11.63B |
Year Ago Sales | 2.5B | 2.45B | 9.91B | 10.47B |
Sales Growth (year/est) | 6.08% | 7.39% | 5.67% | 7.42% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | 0.73 | 0.74 | 0.72 | 0.76 |
EPS Actual | 0.74 | 0.81 | 0.72 | 0.73 |
Difference | 0.01 | 0.07 | 0 | -0.03 |
Surprise % | 1.45% | 8.79% | 0.57% | -4.27% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.76 | 0.84 | 3.23 | 3.83 |
7 Days Ago | 0.79 | 0.82 | 3.3 | 3.89 |
30 Days Ago | 0.82 | 0.82 | 3.25 | 3.8 |
60 Days Ago | 0.82 | 0.8 | 3.29 | 3.87 |
90 Days Ago | 0 | 0 | 3.61 | 4.29 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 2 | -- | 1 |
Up Last 30 Days | -- | 2 | -- | 1 |
Down Last 7 Days | 9 | 5 | 15 | 17 |
Down Last 30 Days | 11 | 7 | 19 | 17 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ALC | 2.70% | 3.70% | 5.92% | 18.49% |
S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
Reiterates | Needham: Buy to Buy | 5/14/2025 |
Maintains | Keybanc: Overweight to Overweight | 3/31/2025 |
Maintains | Mizuho: Outperform to Outperform | 3/28/2025 |
Maintains | Needham: Buy to Buy | 3/28/2025 |
Reiterates | Needham: Buy to Buy | 3/20/2025 |
Maintains | Baird: Outperform to Outperform | 2/27/2025 |
Related Tickers
COO The Cooper Companies, Inc.
72.33
+1.62%
BLCO Bausch + Lomb Corporation
11.70
+0.78%
RGEN Repligen Corporation
128.30
+1.26%
BAX Baxter International Inc.
30.26
+0.36%
BDX Becton, Dickinson and Company
173.45
+1.41%
RMD ResMed Inc.
252.20
+1.01%
WST West Pharmaceutical Services, Inc.
224.69
+2.80%
ATR AptarGroup, Inc.
153.31
+0.54%
HOLX Hologic, Inc.
64.33
+2.00%
STAA STAAR Surgical Company
17.87
+2.70%